Skip to main content

Appraisals - ASAR & FAR

01/03/2022
Appraisal Report: hydrocortisone MR (Efmody) 3017
31/08/2022
Appraisal Report: hydrocortisone (Efmody) 3017
24/02/2020
Appraisal Report: human alpha1-proteinase inhibitor (Respreeza) 47
24/02/2020
Appraisal Report: histamine (Ceplene) 346
24/02/2020
Appraisal Report: guanfacine (Intuniv) 2361 ASAR
31/07/2019
Appraisal Report: green tea leaf extract (Catephen) 2739
20/02/2020
Appraisal Report: glycerol phenylbutyrate (Ravicti) 2127
20/02/2020
Appraisal Report: fosfomycin (Fomicyt) 2710
25/07/2019
Appraisal Report: fosaprepitant (Ivemend) 3789
31/07/2019
Appraisal Report: fingolimod (Gilenya) 3135
20/02/2020
Appraisal Report: fampridine (Fampyra) 3942
31/07/2019
Appraisal Report: evolocumab (Repatha) 2866
12/10/2021
Appraisal Report: everolimus (Votubia) 2142
20/02/2020
Appraisal Report: etanercept (Enbrel) 1437
27/06/2019
Appraisal Report: eslicarbazepine acetate (Zebinix) 1214
20/02/2020
Appraisal Report: enzalutamide (Xtandi) 1773
31/07/2019
Appraisal Report: entecavir (Baraclude) 2546
24/02/2020
Appraisal Report: emtricitabine-tenofovir (Truvada) 1625
31/07/2019
Appraisal Report: emtricitabine/tenofovir alafenamide (Descovy) 2771
31/07/2019
Appraisal Report: elvitegravir combination (Genvoya) 2248
Follow AWTTC: